REM2
COURTESY REMINDER - SEC. 8 (10-YR)/SEC. 9 E-MAILED
02/16/2025
Back to search
Official data from USPTO
CARDIOVAX
Did you know this trademark is already registered in United States?
Before investing in name, identity, and promotion, validate collision risk and registration strategy to avoid wasting time and budget.
Active USPTO registrationType: WordOffice: United States
Quick snapshot
CARDIOVAX
ST13
US500000086535097Class
5, 42
Filing
86535097
Registration
4900535
Risk and opportunity diagnosis
Executive reading for naming, filing, and monitoring decisions.
USPTO status
Active USPTO registration
Case type
Application and registration
Recorded events
23
Latest update
02/16/2025
Trademark type
Word
Nice classes
5, 42
Filing date
02/13/2015
Registration date
02/16/2016
Expiration date
-
Complete case details
Structured fields from the responsible authority and the official record.
Status date
02/01/2023
Last transaction
02/16/2025
Responsible office
United States Patent and Trademark Office
Status code
701
Official register
Principal Register
First use anywhere
09/15/2008
First use in commerce
09/15/2008
Drawing code
4
Owner type
16
Owner location
LOS ANGELES, CA
Examiner
LAW, CHRISTOPHER
Law office
L50
Current location
TMEG LAW OFFICE 105
Holders and representatives
Holders
ABCENTRA
CardioVax, LLC
Representatives
A. Tally Eitan Gornitzky & Co
Technical classification
Nice Classes
Class 5Class 42
Vienna Codes
No Vienna codes available.
Goods and services
Class 5
Medications for treating heart diseaseincluding but not limited to atherosclerosis; vaccines
Class 42
Medicalpharmaceuticalbiotech and clinical research and development of medications and vaccines for treating heart diseaseincluding but not limited to atherosclerosis
Publications
History of USPTO decisions and trademark events.
23 publications found
NAS8
NOTICE OF ACCEPTANCE OF SEC. 8 - E-MAILED
02/01/2023
8.OK
REGISTERED - SEC. 8 (6-YR) ACCEPTED
02/01/2023
APRE
CASE ASSIGNED TO POST REGISTRATION PARALEGAL
02/01/2023
ES8R
TEAS SECTION 8 RECEIVED
07/25/2022
REM1
COURTESY REMINDER - SEC. 8 (6-YR) E-MAILED
02/16/2021
ASGN
AUTOMATIC UPDATE OF ASSIGNMENT OF OWNERSHIP
08/26/2020
R.PR
REGISTERED-PRINCIPAL REGISTER
02/16/2016
NPUB
OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
12/01/2015
PUBO
PUBLISHED FOR OPPOSITION
12/01/2015
NONP
NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
11/11/2015
PREV
LAW OFFICE PUBLICATION REVIEW COMPLETED
10/28/2015
CNSA
APPROVED FOR PUB - PRINCIPAL REGISTER
10/23/2015
TEME
TEAS/EMAIL CORRESPONDENCE ENTERED
10/23/2015
CRFA
CORRESPONDENCE RECEIVED IN LAW OFFICE
10/23/2015
ALIE
ASSIGNED TO LIE
10/20/2015
TROA
TEAS RESPONSE TO OFFICE ACTION RECEIVED
09/30/2015
GNRN
NOTIFICATION OF NON-FINAL ACTION E-MAILED
05/20/2015
GNRT
NON-FINAL ACTION E-MAILED
05/20/2015
CNRT
NON-FINAL ACTION WRITTEN
05/20/2015
DOCK
ASSIGNED TO EXAMINER
05/20/2015
NWOS
NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
03/02/2015
NWAP
NEW APPLICATION ENTERED
02/17/2015
Continuous trademark protection
Get notified about every new filing that threatens CARDIOVAX or your mark.
Professional 24-month watch service: we monitor USPTO for you and alert you in time to oppose — before conflicts become losses.